The arm carries two different claims, cleared four years apart, on two different devices.
Muscle, October 2018: The wording added then reads "Improvement of muscle tone and firmness, for strengthening muscles in arms." That is the entire arm claim for magnetic muscle stimulation. It does not name the biceps or the triceps, and no clearance in this product line does. Anyone quoting a "cleared triceps treatment" is describing wording that does not exist.
Fat, January 2022, and only on the NEO: The wording is "Non-invasive lipolysis (breakdown of fat) of the upper arms limited to skin types II and III and BMI 30 or under." Lipolysis means breakdown of fat. Two limits are written into the sentence: Fitzpatrick skin types II and III only, and a BMI of 30 or under. The abdomen and thigh versions of the same claim cover skin types I to VI with no BMI ceiling. The arm is the narrowest indication in the set.
Notice one more absence. The abdomen and thigh clearances each pair lipolysis with "Reduction in circumference." The upper arm clearance has no circumference claim. Whatever was submitted for the arm, a measured reduction in arm circumference was not part of what was cleared.
A clearance means substantial equivalence to a device already on the market, not proof of a result: It is a comparison exercise. It is not the same standard as drug approval, and it is not a guarantee that you will see anything.
One caveat on how clearances get attributed. BTL files with FDA under model numbers rather than trade names, and FDA does not publish a link between a brand name and a clearance number. The indication wording quoted above is exact. Attaching a brand name to it is a reasonable inference from the device descriptions and the manufacturer's marketing, not an official record.
Most people searching for EmSculpt arm results want the back of the arm to be less soft. So this is the part to be clear about.
Magnetic muscle stimulation works on motor nerves: A coil produces a pulsed magnetic field that induces current in tissue and depolarises motor neurons, making the muscle contract involuntarily and harder than you can contract it yourself. The target is muscle. Every muscle-side clearance in this line is written in muscle language.
The fat claim on the NEO is not the magnetic part. It is the radiofrequency part: The NEO adds heat, and it is the heat that is filed under the fat-device regulation. FDA's own performance testing record for the abdominal version notes a therapy temperature of 40 to 43 degrees Celsius being reached and maintained. On the muscle-only NEO filing, by contrast, the radiofrequency is described as warming the applicator surface to below 40 degrees "thus enhancing the patient's comfort" — the same energy, positioned as comfort rather than as fat treatment.
Whether magnetic stimulation alone injures fat at all is disputed in print: Several manufacturer-linked animal and human histology studies report fat-cell death after HIFEM. Against them sits a study of patients about to have abdominoplasty, in which tissue was sampled 3 to 17 days after treatment. Samples from the cryolipolysis comparison showed a clear inflammatory response and loss of perilipin, a protein that marks intact fat cells. Samples from electromagnetic muscle stimulation kept their perilipin: fat cells viable, no inflammatory response. Its conclusion was that there was "no evidence of an impact injurious or otherwise on subcutaneous fat." The first author affiliation on that paper is a competing device maker. That is a real conflict and it should be weighed, not ignored — but it is a published, methodologically specific challenge, and there is no equally direct rebuttal.
A practical consequence: an arm fat percentage quoted at you was almost certainly produced on the NEO, not on plain EmSculpt: Check which machine is in the room.
This can be listed exhaustively, which tells you how small it is. A 2022 critical review of the field counted 22 arm patients in the entire published HIFEM literature.
Plain EmSculpt, study one: a two-person case study: Four 20-minute treatments of biceps, triceps and calves, measured by MRI. Biceps up 17.1 per cent, triceps up 10.2 per cent, calf muscle up 14.6 per cent, arm fat down 12.8 per cent, calf fat down 9.9 per cent. The authors write that "it will be necessary to continue to validate this outcome in a larger sample size study." Two people.
Plain EmSculpt, study two: 20 people across arms and calves: Seven had arms only, four calves only, nine both. Measured by ultrasound, not MRI. Biceps brachii up 16.13 per cent at three months. Fat over the treated arms and calves down 15.12 per cent at three months. Results peaked at three months and were sustained to six months "with a slight but insignificant decline." Same author as the case study.
That is the whole plain-EmSculpt arm literature: Two papers, one author, ultrasound in the larger one, no control group in either.
EmSculpt NEO, one study: Multicentre, open-label, registered as NCT04596241. Thirty-four enrolled, 28 imaged at one month, 25 at three months. Four 30-minute weekly sessions, measured by MRI. At three months: fat down 25.5 per cent, which is 4.9 mm plus or minus 1.5 mm, and triceps up 23.9 per cent, which is 8.9 mm plus or minus 2 mm. Reported discomfort was 1.58 on a 0 to 10 visual scale. The paper states the authors report no conflicts of interest relevant to its content; both authors declare relationships with the manufacturer in other publications. Flag it and read the number with that in mind.
For context on how the independent literature reads these numbers: a 2025 review of all seven NEO studies found every one was authored by manufacturer medical advisors. A 2023 review of the plain-HIFEM literature found pooled fat thickness reduction of 5.5 mm and muscle thickness increase of 2.2 mm across 14 studies, only one of which had a sham group.
Three specific gaps, all of which get papered over in clinic copy.
No published study has treated the triceps on its own: The case study treated biceps, triceps and calves together. The 20-person study measured biceps brachii. The NEO study measured triceps as part of a whole upper-arm protocol.
No study separates loose skin from fat from muscle on the upper arm: The thing people call a "bat wing" is usually a mix of the three, in proportions that differ by person, and nothing published tells you which component this treatment moves in someone whose main problem is skin.
Neither device carries any skin indication: Not skin tightening, not laxity, not cellulite. The words skin, laxity, dermis, collagen and cellulite do not appear in the indications for use of any of these clearances — muscle side or fat side. The NEO's radiofrequency is a heat energy of the kind used elsewhere for skin, but no skin claim was sought and none was granted. The manufacturer sells a separate device for skin texture and cellulite.
A larger muscle under loose skin can fill the envelope and make it look smoother. That is a plausible explanation for what people report; it is not a skin treatment, and no study has measured skin laxity as an endpoint for either device.
The upper arm is the single easiest area on the body to change with a photograph, and two of the reasons belong to this area alone.
Distance from the torso: An arm resting against the ribcage is compressed and flattened against the body. An arm held a few centimetres out is not. This one difference alone remakes the outline.
Elbow angle and hand position: A slightly flexed elbow, or a hand braced on a hip, tenses the arm. A relaxed hand at the side does not.
The general problem with these photographs, and the untreated-area tell, is covered on the EmSculpt before and after stomach page.
Which device is in the room?: Plain EmSculpt has no fat claim at all. The NEO's arm fat claim applies to skin types II and III and BMI 30 or under.
Is my skin type and BMI inside the cleared range for the arm?: Outside it, use is off-label. Off-label treatment is legal and common; it just is not what was cleared or studied.
What do you think my upper arm is made of?: Fat, muscle, loose skin, or a mix. Nothing here treats skin.
Where does that percentage come from?: For arms there are only three published studies, with 2, 20 and 25 measured people.
Will I be weighed at each visit?: If not, your own before-and-after has the same flaw as the studies.
Tell the clinic in advance about an implanted electronic device — pacemaker, defibrillator, nerve stimulator — or any metal implant in or near the field, including plates, screws or a shoulder or elbow replacement. These are contraindications for powered muscle stimulators as a class. Say if you have a cancer diagnosis involving the area.
Say what your Fitzpatrick skin type is and what your BMI is, and ask directly whether you fall inside the cleared arm indication. If the answer is no, ask for that to be said plainly rather than glossed over.
Ask for standardised photographs: same distance, same lens, same light, same arm position, same distance from the torso. Ask for arm circumference to be measured at a marked, recorded point rather than wherever the tape lands.
Fever together with spreading redness, warmth or pus at the treated area. These are signs of a spreading infection and need urgent same-day care.
A blister or open, weeping burn on the treated skin.
A firm lump develops in the treated arm and does not settle over a couple of weeks.
Aching keeps increasing after about day three instead of easing. Soreness like the day after hard exercise is the commonly reported after-effect and it settles on its own.
The skin over the treated area stays red, darkens, or feels persistently numb or tingly.
Weakness or a change in how the arm moves develops and does not recover.
You were sold arm fat reduction and the device is plain EmSculpt, or your skin type or BMI sits outside the cleared arm indication. Both are worth a direct conversation about what you paid for.